
The global market for Ribonucleic Acid Ingredients was valued at US$ 3771 million in the year 2024 and is projected to reach a revised size of US$ 5863 million by 2031, growing at a CAGR of 6.6% during the forecast period.
A synthesized from DNA by an enzyme known as RNA polymerase during a process called transcription.
The global ribonucleic acid (RNA) ingredients market refers to the industry involved in the production and distribution of various RNA-based ingredients used in different sectors, including pharmaceuticals, biotechnology, agriculture, and research laboratories. RNA ingredients play a crucial role in a wide range of applications, including therapeutic development, gene expression analysis, genetic engineering, and molecular diagnostics.
Here are some key insights into the global RNA ingredients market:
Market Overview:
The global RNA ingredients market has been witnessing steady growth due to the increasing adoption of RNA-based technologies in various industries. RNA ingredients are widely used for their ability to regulate gene expression, perform cellular functions, and as tools in molecular biology research.
Types of RNA Ingredients:
The market for RNA ingredients can be categorized based on their types, including:
Messenger RNA (mRNA): mRNA is a form of RNA that carries genetic information from DNA to the ribosomes, where it is used as a template for protein synthesis. mRNA ingredients find applications in vaccine development, gene therapy, and regenerative medicine.
Transfer RNA (tRNA): tRNA molecules play a crucial role in protein synthesis by delivering amino acids to the ribosomes. tRNA ingredients are used in various research and diagnostic applications involving protein synthesis and translation.
Ribosomal RNA (rRNA): rRNA molecules are a component of ribosomes, the cellular machinery responsible for protein synthesis. rRNA ingredients find applications in research laboratories and biotechnological processes involved in protein production.
Small Interfering RNA (siRNA): siRNA molecules are used in genetic research and therapeutics to selectively inhibit the expression of target genes. siRNA ingredients have potential applications in disease treatment, including cancer therapy and genetic disorders.
Applications:
RNA ingredients have a wide range of applications in various industries:
Pharmaceuticals and Biotechnology: RNA ingredients are extensively used in drug discovery, therapeutic development (including mRNA-based vaccines and gene therapy), and personalized medicine. RNA-based technologies offer new possibilities for treating diseases at the genetic level.
Agriculture and Crop Science: RNA ingredients are explored for their potential in genetic engineering and crop improvement. They can be used to modify gene expression in plants, enhancing traits such as disease resistance, yield, and nutritional content.
Research and Diagnostics: RNA ingredients are valuable tools in research laboratories for gene expression analysis, studying cellular processes, and understanding disease mechanisms. They are also used in molecular diagnostics to detect specific RNA sequences associated with diseases.
Market Dynamics:
The global RNA ingredients market is influenced by several factors, including:
Advancements in RNA-based technologies and their increasing adoption across industries.
Growing demand for personalized medicine and targeted therapies.
Government initiatives and funding for RNA research and development.
Increased focus on genetic engineering and genetically modified organisms in agriculture.
Market Outlook:
The global RNA ingredients market is expected to witness continued growth in the coming years, driven by ongoing advancements in RNA-based technologies, increasing research activities, and rising demand for personalized medicine. The market is likely to see new product launches, collaborations, and strategic partnerships as companies strive to innovate and cater to the evolving needs of different industries.
This report aims to provide a comprehensive presentation of the global market for Ribonucleic Acid Ingredients, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ribonucleic Acid Ingredients.
The Ribonucleic Acid Ingredients market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Ribonucleic Acid Ingredients market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ribonucleic Acid Ingredients companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BioNTech SE
Moderna
Abogen Biosciences
Ionis Pharmaceuticals
Sarepta Therapeutics
Alnylam Pharmaceuticals
LARONDE, Inc.
Sirnaomics, Inc.
Deep Genomics
Nutcracker Therapeutics
Segment by Type
Messenger RNA
Transfer RNA
Ribosomal RNA
Segment by Application
Fluorescent Dyes
RT-PCR Enzymes
Transcription Reagents
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ribonucleic Acid Ingredients company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ribonucleic Acid Ingredients Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Messenger RNA
1.2.3 Transfer RNA
1.2.4 Ribosomal RNA
1.3 Market by Application
1.3.1 Global Ribonucleic Acid Ingredients Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Fluorescent Dyes
1.3.3 RT-PCR Enzymes
1.3.4 Transcription Reagents
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Ribonucleic Acid Ingredients Market Perspective (2020-2031)
2.2 Global Ribonucleic Acid Ingredients Growth Trends by Region
2.2.1 Global Ribonucleic Acid Ingredients Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Ribonucleic Acid Ingredients Historic Market Size by Region (2020-2025)
2.2.3 Ribonucleic Acid Ingredients Forecasted Market Size by Region (2026-2031)
2.3 Ribonucleic Acid Ingredients Market Dynamics
2.3.1 Ribonucleic Acid Ingredients Industry Trends
2.3.2 Ribonucleic Acid Ingredients Market Drivers
2.3.3 Ribonucleic Acid Ingredients Market Challenges
2.3.4 Ribonucleic Acid Ingredients Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ribonucleic Acid Ingredients Players by Revenue
3.1.1 Global Top Ribonucleic Acid Ingredients Players by Revenue (2020-2025)
3.1.2 Global Ribonucleic Acid Ingredients Revenue Market Share by Players (2020-2025)
3.2 Global Ribonucleic Acid Ingredients Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Ribonucleic Acid Ingredients Revenue
3.4 Global Ribonucleic Acid Ingredients Market Concentration Ratio
3.4.1 Global Ribonucleic Acid Ingredients Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ribonucleic Acid Ingredients Revenue in 2024
3.5 Global Key Players of Ribonucleic Acid Ingredients Head office and Area Served
3.6 Global Key Players of Ribonucleic Acid Ingredients, Product and Application
3.7 Global Key Players of Ribonucleic Acid Ingredients, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Ribonucleic Acid Ingredients Breakdown Data by Type
4.1 Global Ribonucleic Acid Ingredients Historic Market Size by Type (2020-2025)
4.2 Global Ribonucleic Acid Ingredients Forecasted Market Size by Type (2026-2031)
5 Ribonucleic Acid Ingredients Breakdown Data by Application
5.1 Global Ribonucleic Acid Ingredients Historic Market Size by Application (2020-2025)
5.2 Global Ribonucleic Acid Ingredients Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Ribonucleic Acid Ingredients Market Size (2020-2031)
6.2 North America Ribonucleic Acid Ingredients Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Ribonucleic Acid Ingredients Market Size by Country (2020-2025)
6.4 North America Ribonucleic Acid Ingredients Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Ribonucleic Acid Ingredients Market Size (2020-2031)
7.2 Europe Ribonucleic Acid Ingredients Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Ribonucleic Acid Ingredients Market Size by Country (2020-2025)
7.4 Europe Ribonucleic Acid Ingredients Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Ribonucleic Acid Ingredients Market Size (2020-2031)
8.2 Asia-Pacific Ribonucleic Acid Ingredients Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Ribonucleic Acid Ingredients Market Size by Region (2020-2025)
8.4 Asia-Pacific Ribonucleic Acid Ingredients Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Ribonucleic Acid Ingredients Market Size (2020-2031)
9.2 Latin America Ribonucleic Acid Ingredients Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Ribonucleic Acid Ingredients Market Size by Country (2020-2025)
9.4 Latin America Ribonucleic Acid Ingredients Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ribonucleic Acid Ingredients Market Size (2020-2031)
10.2 Middle East & Africa Ribonucleic Acid Ingredients Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Ribonucleic Acid Ingredients Market Size by Country (2020-2025)
10.4 Middle East & Africa Ribonucleic Acid Ingredients Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BioNTech SE
11.1.1 BioNTech SE Company Details
11.1.2 BioNTech SE Business Overview
11.1.3 BioNTech SE Ribonucleic Acid Ingredients Introduction
11.1.4 BioNTech SE Revenue in Ribonucleic Acid Ingredients Business (2020-2025)
11.1.5 BioNTech SE Recent Development
11.2 Moderna
11.2.1 Moderna Company Details
11.2.2 Moderna Business Overview
11.2.3 Moderna Ribonucleic Acid Ingredients Introduction
11.2.4 Moderna Revenue in Ribonucleic Acid Ingredients Business (2020-2025)
11.2.5 Moderna Recent Development
11.3 Abogen Biosciences
11.3.1 Abogen Biosciences Company Details
11.3.2 Abogen Biosciences Business Overview
11.3.3 Abogen Biosciences Ribonucleic Acid Ingredients Introduction
11.3.4 Abogen Biosciences Revenue in Ribonucleic Acid Ingredients Business (2020-2025)
11.3.5 Abogen Biosciences Recent Development
11.4 Ionis Pharmaceuticals
11.4.1 Ionis Pharmaceuticals Company Details
11.4.2 Ionis Pharmaceuticals Business Overview
11.4.3 Ionis Pharmaceuticals Ribonucleic Acid Ingredients Introduction
11.4.4 Ionis Pharmaceuticals Revenue in Ribonucleic Acid Ingredients Business (2020-2025)
11.4.5 Ionis Pharmaceuticals Recent Development
11.5 Sarepta Therapeutics
11.5.1 Sarepta Therapeutics Company Details
11.5.2 Sarepta Therapeutics Business Overview
11.5.3 Sarepta Therapeutics Ribonucleic Acid Ingredients Introduction
11.5.4 Sarepta Therapeutics Revenue in Ribonucleic Acid Ingredients Business (2020-2025)
11.5.5 Sarepta Therapeutics Recent Development
11.6 Alnylam Pharmaceuticals
11.6.1 Alnylam Pharmaceuticals Company Details
11.6.2 Alnylam Pharmaceuticals Business Overview
11.6.3 Alnylam Pharmaceuticals Ribonucleic Acid Ingredients Introduction
11.6.4 Alnylam Pharmaceuticals Revenue in Ribonucleic Acid Ingredients Business (2020-2025)
11.6.5 Alnylam Pharmaceuticals Recent Development
11.7 LARONDE, Inc.
11.7.1 LARONDE, Inc. Company Details
11.7.2 LARONDE, Inc. Business Overview
11.7.3 LARONDE, Inc. Ribonucleic Acid Ingredients Introduction
11.7.4 LARONDE, Inc. Revenue in Ribonucleic Acid Ingredients Business (2020-2025)
11.7.5 LARONDE, Inc. Recent Development
11.8 Sirnaomics, Inc.
11.8.1 Sirnaomics, Inc. Company Details
11.8.2 Sirnaomics, Inc. Business Overview
11.8.3 Sirnaomics, Inc. Ribonucleic Acid Ingredients Introduction
11.8.4 Sirnaomics, Inc. Revenue in Ribonucleic Acid Ingredients Business (2020-2025)
11.8.5 Sirnaomics, Inc. Recent Development
11.9 Deep Genomics
11.9.1 Deep Genomics Company Details
11.9.2 Deep Genomics Business Overview
11.9.3 Deep Genomics Ribonucleic Acid Ingredients Introduction
11.9.4 Deep Genomics Revenue in Ribonucleic Acid Ingredients Business (2020-2025)
11.9.5 Deep Genomics Recent Development
11.10 Nutcracker Therapeutics
11.10.1 Nutcracker Therapeutics Company Details
11.10.2 Nutcracker Therapeutics Business Overview
11.10.3 Nutcracker Therapeutics Ribonucleic Acid Ingredients Introduction
11.10.4 Nutcracker Therapeutics Revenue in Ribonucleic Acid Ingredients Business (2020-2025)
11.10.5 Nutcracker Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
BioNTech SE
Moderna
Abogen Biosciences
Ionis Pharmaceuticals
Sarepta Therapeutics
Alnylam Pharmaceuticals
LARONDE, Inc.
Sirnaomics, Inc.
Deep Genomics
Nutcracker Therapeutics
Ìý
Ìý
*If Applicable.
